SEC Company Response from Somaxon Pharmaceuticals, Inc. (CIK 0001339455) — Dec 13, 2005
Somaxon Pharmaceuticals, Inc. (CIK 0001339455)
Date: Dec. 13, 2005 · CIK: 0001339455 · Accession: 0000936392-05-000434
AI Filing Summary & Sentiment
File numbers found in text: 333-128871
Letter
VIA EDGAR AND FACSIMILE Re: Somaxon Pharmaceuticals, Inc. Amendment No. 2 to Registration Statement on Form S-1 SEC File No. 333-128871
Dear Mr. Hasan:
Enclosed please find correspondence from November 23, 2005 accompanying the above-referenced Registration Statement. We are refiling the correspondence as requested by the Staff. Please do not hesitate to call me at (619) 238-2857 or Cheston Larson at (858) 523-5435 with any questions.
Best regards,
/s/ Danielle M. Donaldson
Show Raw Text
COVER
2
filename2.htm
cover
12636 High Bluff Drive, Suite 400
San Diego, California 92130-2071
Tel: (858) 523-5400 Fax: (858) 523-5450
www.lw.com
FIRM / AFFILIATE OFFICES
Boston
New York
Brussels
Northern Virginia
Chicago
Orange County
Frankfurt
Paris
Hamburg
San Diego
Hong Kong
San Francisco
London
Shanghai
Los Angeles
Silicon Valley
Milan
Singapore
Moscow
Tokyo
New Jersey
Washington, D.C.
File No. 036854-0010
December 13, 2005
VIA EDGAR AND FACSIMILE
Zafar Hasan, Esq.
Attorney-Advisor
U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 6010
Washington, D.C. 20549
Re:
Somaxon Pharmaceuticals, Inc.
Amendment No. 2 to Registration Statement on Form S-1
SEC File No. 333-128871
Dear Mr. Hasan:
Enclosed please find correspondence from November 23, 2005 accompanying the above-referenced
Registration Statement. We are refiling the correspondence as requested by the Staff. Please do
not hesitate to call me at (619) 238-2857 or Cheston Larson at (858) 523-5435 with any questions.
Best regards,
/s/ Danielle M. Donaldson
Danielle M. Donaldson
of LATHAM & WATKINS LLP
Enclosures
cc:
Kenneth M. Cohen, Somaxon Pharmaceuticals, Inc.
Scott N. Wolfe, Latham & Watkins LLP
Cheston J. Larson, Latham & Watkins LLP